Michael Barbella, Managing Editor01.10.23
InfuSystem Holdings Inc. and Sanara MedTech Inc. have established a partnership, SI Wound Care LLC to help improve patient outcomes, lower care costs, and boost patient and provider satisfaction. The collaboration will enable InfuSystem to offer products including Cork Medical LLC negative pressure wound therapy (NPWT) devices and supplies and Sanara’s advanced wound care product line to new customers.
“Over the past few years, we have built our NPWT business as a turnkey solution with a focus on offering high quality options to patients and providers," InfuSystem CEO Richard DiIorio stated. "We believe the wound care market represents a significant opportunity to drive revenue growth for our Integrated Therapy Services (“ITS”) platform by treating both chronic and acute wounds. Partnering with Sanara enables us to better serve patients and care providers nationally by offering a complete line of advanced wound care products.”
Both companies bring a differentiated and complementary offering to the companies’ combined solution:
With a focus on improving patient outcomes through evidence-based healing solutions, Sanara MedTech Inc. markets, distributes, and develops wound and skincare products for use by physicians and clinicians in hospitals, clinics, and all post-acute care settings and offers wound care and dermatology virtual consultation services via telemedicine. Sanara’s products are primarily sold in the North American advanced wound care and surgical tissue repair markets. Sanara markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft, and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of biologic products focusing on AMPLIFY Verified Inductive Bone Matrix, ALLOCYTE Advanced Cellular Bone Matrix, BiFORM Bioactive Moldable Matrix, and TEXAGEN Amniotic Membrane Allograft to the surgical market. Sanara’s pipeline also contains product candidates for mitigation of opportunistic pathogens and biofilm, wound re-epithelialization and closure, necrotic tissue debridement, and cell compatible substrates.
InfuSystem Holdings Inc. is a national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is ITS, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The ITS segment is comprised of Oncology, Pain Management, Wound Therapy and Lymphedema businesses. The second platform, Durable Medical Equipment Services, supports the ITS platform and leverages strong service orientation to win incremental business from its direct payer clients. The DME Services segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Mich., the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.
“Over the past few years, we have built our NPWT business as a turnkey solution with a focus on offering high quality options to patients and providers," InfuSystem CEO Richard DiIorio stated. "We believe the wound care market represents a significant opportunity to drive revenue growth for our Integrated Therapy Services (“ITS”) platform by treating both chronic and acute wounds. Partnering with Sanara enables us to better serve patients and care providers nationally by offering a complete line of advanced wound care products.”
Both companies bring a differentiated and complementary offering to the companies’ combined solution:
- Sanara - Sanara's team has significant wound care expertise in the acute care setting as well as throughout the entire continuum of care. Sanara claims its wound care portfolio is complementary to NPWT services and can be used before, during, or after NPWT to remove microbes from the wound bed and promote healing.
- InfuSystem - InfuSystem is a participating in-network provider for more than 770 health insurance networks covering more than 95% of the U.S. population and has seven North American distribution centers. InfuSystem can leverage this infrastructure to gain acceptance for the new products and services. Additionally, InfuSystem is a distributor of Cork NPWT devices and supplies in the United States and Canada. The partnership will enable InfuSystem to offer new products and thereby reach new NPWT business throughout the continuum of care, from the hospital to the home.
With a focus on improving patient outcomes through evidence-based healing solutions, Sanara MedTech Inc. markets, distributes, and develops wound and skincare products for use by physicians and clinicians in hospitals, clinics, and all post-acute care settings and offers wound care and dermatology virtual consultation services via telemedicine. Sanara’s products are primarily sold in the North American advanced wound care and surgical tissue repair markets. Sanara markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft, and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of biologic products focusing on AMPLIFY Verified Inductive Bone Matrix, ALLOCYTE Advanced Cellular Bone Matrix, BiFORM Bioactive Moldable Matrix, and TEXAGEN Amniotic Membrane Allograft to the surgical market. Sanara’s pipeline also contains product candidates for mitigation of opportunistic pathogens and biofilm, wound re-epithelialization and closure, necrotic tissue debridement, and cell compatible substrates.
InfuSystem Holdings Inc. is a national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is ITS, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The ITS segment is comprised of Oncology, Pain Management, Wound Therapy and Lymphedema businesses. The second platform, Durable Medical Equipment Services, supports the ITS platform and leverages strong service orientation to win incremental business from its direct payer clients. The DME Services segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Mich., the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.